lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

COVID-19 in HIV-Infected Individuals: Preliminary Results of a Prospective Cohort

35 Pages Posted: 2 Jun 2020

See all articles by Pilar Vizcarra

Pilar Vizcarra

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

María Jesús Pérez-Elías

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases; Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carmen Quereda

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Ana Moreno

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

María Jesús Vivancos

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Fernando Dronda

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

José Luis Casado

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

More...

Abstract

Background: Information about incidence, clinical characteristics and outcomes of HIV-infected individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is scarce. We characterized individuals with coronavirus disease 2019 (COVID-19) among a cohort of HIV-infected adults regularly followed-up at an HIV clinic in Madrid, Spain, one of the most affected cities worldwide.

Methods: In this observational study, we included all consecutive HIV-infected individuals who were diagnosed of suspected or confirmed COVID-19 as of April 14, 2020. Demographic, clinical, treatment, and laboratory data, including HIV-specific information, were extracted from the electronic health records. We compared the characteristics of HIV-infected individuals with COVID-19 with a representative sample of HIV-infected individuals evaluated before the COVID-19 pandemic (n=1,302), and described the evolution and outcomes of individuals with COVID-19 according to baseline characteristics.

Findings: Thirty-seven HIV-infected individuals (mean, 53·5 years; females, 16%) were diagnosed with COVID-19 (incidence, 1·3%, 95% confidence interval: 0·9-1·8%). Of them, 29 (78%) were laboratory confirmed cases, and 26 (70%) required hospitalization. Overall, 29 (78%) individuals had comorbidities, predominantly hypertension and diabetes, higher than that observed among HIV-infected individuals without COVID-19 ( P =0·006). Additionally, a significantly higher percentage of individuals with COVID-19 were receiving tenofovir prior to COVID-19 diagnosis compared to HIV-infected individuals without COVID-19 (70% versus 52%, P =0·030), and the rate of prior protease inhibitor use was similar in both groups (mostly darunavir, 19% versus 18%, P =0·830). Clinical, analytical and radiological presentation of COVID-19 in HIV-infected individuals was similar to that described in the general population: five (14%) were critically-ill, and two (5%) died. Two out of five critically ill individuals had CD4+ counts <200 cells/mm3.

Interpretation: Our findings indicate that COVID-19 predominantly affects HIV-infected individuals with comorbidities. These data do not suggest a protective effect of CD4+ count or previous antiretroviral therapy on the rate of infection or outcomes.

Funding Statement: None.

Declaration of Interests: MJPE has received research grants or honoraria for lectures or for participation in advisory boards from Abbott, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead Sciences, ViiV-Healthcare previously GlaxoSmithKline, Roche, and Janssen; and unrestricted grants from Abbott, ViiVHealthcare previously GlaxoSmithKline, Gilead Sciences and Janssen. For the remaining authors, none was declared.

Ethics Approval Statement: The study protocol was approved by our Institutional Review Board (EC 110/20), and patients provided oral informed consent in order to minimize staff exposure.

Keywords: SARS-CoV-2; coronavirus disease 19; HIV; cohort; clinical characteristics; infection rate; Spain

Suggested Citation

Vizcarra, Pilar and Pérez-Elías, María Jesús and Quereda, Carmen and Moreno, Ana and Vivancos, María Jesús and Dronda, Fernando and Casado, José Luis, COVID-19 in HIV-Infected Individuals: Preliminary Results of a Prospective Cohort (4/25/2020). Available at SSRN: https://ssrn.com/abstract=3588554 or http://dx.doi.org/10.2139/ssrn.3588554

Pilar Vizcarra (Contact Author)

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases ( email )

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain
34913368672 (Phone)
34913369100 (Fax)

María Jesús Pérez-Elías

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

Carmen Quereda

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

Ana Moreno

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

María Jesús Vivancos

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

Fernando Dronda

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

José Luis Casado

Hospital Universitario Ramón y Cajal - Department of Infectious Diseases

Carretera de Colmenar, Km. 9,100
Madrid, 28034
Spain

Click here to go to TheLancet.com

Paper statistics

Abstract Views
323
Downloads
36